Specialist Consultant Paediatrician and Honorary Senior Fellow, Postgraduate Institute of Medicine, University of Colombo, ...

FDA unveils a priority voucher program to accelerate drug reviews for national priorities, using a team-based review model.

Aldeyra has resubmitted its new drug application for reproxalap, an investigational dry eye treatment, which contained new ...

The Food and Drug Administration announced the launch of a new program to fast-track agency approvals for drug manufacturers ...

The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.

Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient ...

The global bioprocessing equipment market was valued at USD 62.3 billion in 2024 and is expected to reach approximately USD ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients' lives.

The US Food and Drug Administration (FDA) has approved Ocugen’s investigational new drug (IND) amendment to initiate a Phase ...

Glaucoma is the most common cause of irreversible blindness and affects 80 million people around the world. Pete Williams, ...